Throughout my time in public service, I have been committed to holding accountable those who misuse taxpayer dollars and engage in corruption.

but as we wait for the Senate to act, we must pursue other crucial reforms. I am honored to continue serving Kentucky’s 1st Congressional District and the American people as the Ranking Member of the Committee on Oversight and Reform.

Lastly, the letter requests the data brokers and health apps to provide documents and information by 21 July 2022. The House Oversight Committee is the main investigative committee in the. This includes the recent supplemental funding 1designed to assist Ukraine. In 2007 House Democrats changed the name to the Committee on Oversight and Government Reform, and finally, in 2019 to its current name, the Committee on Oversight and Reform. It was renamed the Committee on Government Reform. taxpayer funds that are vulnerable to waste, fraud, abuse, and mismanagement. In 1999, the committee also assumed oversight responsibilities for the US Post Office and for the civil service. In light of this, the Oversight Committee requested information and documents regarding data privacy, collection, distribution, use, and sale to the aforementioned companies. The House Committee on Oversight and Reform must follow its mandate to conduct oversight of the expenditures of U.S. Wade, data brokers have been found to sell sensitive user location data and mobile phone location data from individuals who have visited health care clinics that provide abortions, leading to concerns about the misuse of private data to target individuals seeking this care. In particular, the Oversight Committee highlighted that, following the Supreme Court's decision to overturn Roe v. The Chairwoman of the Committee on Oversight and Reform ('the Oversight Committee'), along with the Chairman of the Subcommittee on Economic and Consumer Policy sent, on 8 July 2022, letters to five data broker companies and five personal health application companies, requesting information and documents regarding the collection and sale of personal reproductive health data.

Committee on oversight and reform